Quality of Evidence Supporting the Role of Acupuncture for the Treatment of Irritable Bowel Syndrome
Huang et al. · Pain Research and Management · 2021
OBJECTIVE
To systematically assess the quality of evidence on acupuncture for irritable bowel syndrome (IBS)
WHO
10 systematic reviews and meta-analyses involving 664-3,440 participants
DURATION
Studies published from 2010 to 2020
POINTS
Specific points not detailed in the included reviews
🔬 Study Design
Acupuncture vs Conventional Medication
n=9
Comparison of acupuncture with conventional drugs
Acupuncture vs Sham
n=2
True acupuncture vs placebo
Acupuncture + Chinese Herbs
n=1
Combined therapy
📊 Results in numbers
Reviews with high methodological quality
Results with high-quality evidence
Efficacy rate, acupuncture vs medication
Quality-of-life improvement (IBS-QOL)
Percentage highlights
📊 Outcome Comparison
AMSTAR-2 Methodological Quality
Moderate Quality Evidence
This research analyzed the quality of studies on acupuncture for irritable bowel syndrome. Although some studies suggest benefits from acupuncture, most of the research is of low quality, which means the results must be interpreted with caution.
Article summary
Plain-language narrative summary
This study represents a comprehensive review of the scientific evidence available on the use of acupuncture in the treatment of irritable bowel syndrome (IBS). The researchers conducted a systematic analysis of 10 systematic reviews and meta-analyses published between 2010 and 2020, including data from approximately 14,000 participants. The methodology employed rigorous assessment tools: AMSTAR-2 for methodological quality, PRISMA for reporting quality, and GRADE for evidence quality. The results revealed a concerning picture of the available evidence quality.
Only one of the 10 reviews analyzed (10%) met the criteria for high methodological quality according to AMSTAR-2, while the rest were classified as low or very low quality. The main deficiencies identified included the absence of preestablished protocols (80% of reviews), inadequately described search strategies (60%), and lack of lists of excluded studies (90%). With respect to clinical evidence, no outcome was rated as high quality by the GRADE system. Of the 25 outcome indicators analyzed, only 12 received moderate quality classifications, while the remainder were considered low or very low quality.
The main factors contributing to evidence downgrading were risk of bias, imprecision, inconsistency, and publication bias. As for therapeutic outcomes, nine studies compared acupuncture with conventional medication, showing that patients treated with acupuncture had better efficacy rates (RR 1.17-1.28), reduced recurrence rates, and improvement in IBS symptom scores and quality of life. Two studies compared true acupuncture with sham acupuncture and found no statistically significant differences in efficacy rate, quality of life, or symptom severity. One study evaluated the combination of acupuncture with Chinese herbal medicine versus conventional medication, demonstrating superiority of the combined therapy in efficacy rate and reduction of abdominal pain.
The proposed mechanisms for the efficacy of acupuncture in IBS include regulation of gastrointestinal motility, reduction of visceral hypersensitivity, modulation of the brain-gut axis, decreased intestinal mucosal inflammation, promotion of intestinal microflora balance, and adjustment of psychological status. Animal studies suggest that acupuncture has a bidirectional regulatory effect on intestinal motility, benefiting both patients with predominant diarrhea and those with predominant constipation. The clinical implications of this study are significant. Although acupuncture may be a promising therapy for IBS and potentially useful as an adjunct to conventional treatment, this conclusion must be interpreted with extreme caution given the overall low quality of the available evidence.
The authors emphasize the urgent need for well-designed and well-implemented randomized clinical trials to provide more robust evidence on the efficacy of acupuncture in IBS. Limitations include the subjective nature of the assessment tools used and limited evidence for specific IBS subtypes. This work represents a valuable contribution to the field by systematically mapping the quality of the evidence and identifying important gaps in research on acupuncture for IBS.
Strengths
- 1Rigorous methodology using three validated assessment tools
- 2Comprehensive analysis of 10 systematic reviews
- 3Clear identification of methodological deficiencies
- 4Prospective protocol registration in PROSPERO
Limitations
- 1Inherent subjectivity of the assessment tools
- 2Most included studies of low quality
- 3Limited evidence for specific IBS subtypes
- 4Lack of data on specific acupuncture points
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Irritable bowel syndrome is a highly prevalent functional condition in the pain and rehabilitation clinic, frequently associated with comorbidities such as fibromyalgia, chronic low back pain, and anxiety disorders — patients who arrive at our service through other referral routes. This umbrella review, with data from approximately 14,000 participants, consolidates what is known about the use of acupuncture in IBS and offers a useful map of the current state of the evidence. The finding of RR between 1.17 and 1.28 favoring acupuncture compared with conventional medication, and SMD of 0.75 to 2.37 on quality of life, are clinically relevant signals that justify considering acupuncture as an adjuvant in patients with unsatisfactory response to standard pharmacological treatment, especially those with a strong component of visceral hypersensitivity and altered central modulation — a profile we frequently identify at the interface of chronic pain and functional gastrointestinal disorder.
▸ Notable Findings
The most noteworthy aspect is not merely the direction of effect — favorable to acupuncture versus conventional medication — but the mechanistic plausibility the article articulates with consistency: bidirectional regulation of intestinal motility, modulation of the brain-gut axis, reduction of visceral hypersensitivity, and impact on the intestinal microflora. This mechanistic profile resonates directly with the central sensitization model we use to understand IBS in the context of chronic pain. The finding of a bidirectional regulatory effect — benefiting both the diarrhea-predominant subtype and the constipation-predominant subtype — suggests a neuromodulatory action that goes beyond purely isolated sympathetic or parasympathetic effects. The combination with Chinese herbal medicine surpassed conventional medication in efficacy and abdominal pain reduction, opening space to investigate therapeutic combinations within a structured integrative approach.
▸ From My Experience
In my practice, patients with IBS typically arrive at the pain service after years of unsatisfactory gastroenterological management, carrying an evident central sensitization profile — visceral allodynia, nonrestorative sleep, catastrophizing. I have observed initial clinical response as early as the third or fourth session, especially in modulation of abdominal pain and overall sense of well-being. For maintenance, we usually work with cycles of eight to twelve sessions, with reassessment at the end of each cycle. The turning point usually occurs when we combine acupuncture with autonomic regulation strategies — diaphragmatic breathing, sleep hygiene — and, when necessary, low-dose neuromodulatory medication. The profile that responds best, in my experience, is the patient with a predominant anxiety component and symptom variability associated with stress. Patients with an active or structural inflammatory bowel condition are not candidates and need to be adequately screened before referral.
Full original article
Read the full scientific study
Pain Research and Management · 2021
DOI: 10.1155/2021/2752246
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories